The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure

Journal of the American College of Cardiology

Volumn 40, Issue 6, 2002, Pages 1106-1113

  Mahon, Niall G ^a   Blackstone, Eugene H ^a   Francis, Gary S ^a   Starling III, Randall C ^a   Young, James B ^a   Lauer, Michael S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIAGNOSTIC VALUE; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; OUTCOMES RESEARCH; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; WALKING;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; CHRONIC DISEASE; CREATININE; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; WALKING;

EID: 0037130778     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02125-3     Document Type: Article

References (35)

1. Guidelines for the evaluation and management of heart failure: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)
2. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction
3. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction
4. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure
5. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?
6. The effect of digoxin on mortality and morbidity in patients with heart failure
7. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: A large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure
8. Dead is dead - Artificial definitions are no substitute
9. Cause of death in clinical research: Time for a reassessment?
10. Prediction of creatinine clearance from serum creatinine
11. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure
12. Nonparametric estimation from incomplete observations
13. Regression models and life tables
14. A Bayesian analysis of the minimum AIC procedure
15. The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model
16. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
17. The decomposition of time-varying hazard into phases, each incorporating a separate stream on concomitant information
18. Effect of oral milrinone on mortality in severe chronic heart failure: The PROMISE study research group
19. Chronic congestive heart failure: Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms
20. Insights into the contemporary epidemiology and outpatient management of congestive heart failure
21. Survival of patients with a new diagnosis of heart failure: A population based study
22. Reversal of left ventricular dysfunction after renal transplantation
23. Reversal of cardiac dysfunction secondary, to type 1 primary hyperoxaluria after combined liver-kidney transplantation
24. Improvement of left ventricular function after renal transplantation in a patient with uremic cardiomyopathy: Report of a case
25. Sustained improvements in cardiac geometry and function following kidney-pancreas transplantation
26. Impact of renal transplantation on uremic cardiomyopathy
27. Inaccuracy of estimated creatinine clearance for prediction of iothalamate glomerular filtration rate
28. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study
29. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
30. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
31. Oxygen consumption during corridor walk testing in chronic cardiac failure
32. The ability of a submaximal exercise test to predict maximal exercise capacity in patients with heart failure
33. Assessment of oxygen uptake during the six-minute walk test in patients with heart failure
34. The 6-min walk and peak oxygen consumption in advanced heart failure: Aerobic capacity and survival
35. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation